Navigation Links
The CAI, NIH & NCI Partnership: The NCI Invention Portfolio for High Commercial Potential Based on CAI’s Proprietary and Rigorous Business Market and Scientific Criteria
Date:8/1/2013

Bethesda, Maryland (PRWEB) August 01, 2013

The Center for Advancing Innovation, INC (CAI), a globally focused private-public partnership with an over-arching mission to drive successful innovation entered into a Partnership Intermediary Agreement (PIA) with the National Institutes of Health’s (NIH) Office of Technology Transfer (OTT) and the National Cancer Institute (NCI) Technology Transfer Center (TTC).

As a partnership intermediary for NIH OTT and the NCI, the team from CAI, which includes over 20 Ph.D.s, MBAs and other analysts, is assisting the NCI and NIH to accelerate the commercialization of NCI technologies. Using CAI’s robust and unique portfolio assessment model, the partners are working together to evaluate the NCI patent portfolio consisting of thousands of NCI intramural technologies in the areas of drugs, vaccines, therapeutics, diagnostics and medical devices. Through this assessment model, CAI, NCI and NIH have worked together to identify those inventions anticipated to have significant impact on the public health. Recently we reached a significant milestone, as we have identified the top 50 near-term, commercially viable inventions. CAI will also coordinate interest with small businesses, the biopharmaceutical industry and educational institutions to match NCI technologies for possible collaboration and transfer for commercialization.

According to Tom Stackhouse, Associate Director of the Technology Transfer Center at NCI, the NCI TTC and NIH OTT will be working with CAI to accelerate and increase the volume of commercial development and licensing of innovative technologies coming from the NCI and NIH intramural research programs. He also noted that NCI is already seeing the benefit from this partnership via several new opportunities between potential licensees, collaboration partners and NIH inventors.

“CAI’s partnership with the NIH and NCI is an ideal foundation to commercialize intramural inventions and make a sustainable impact on world health and the nation’s economy,” said Rosemarie Truman, CAI Founder and CEO. “We’re strongly encouraged about our collective team’s progress and we are in the process of engaging economic development organizations, entrepreneurs, foundations, large pharmas and other organizations as potential partners to perform additional R&D with the NCI labs.”

The most exciting phase of this new partnership is developing new models for moving technology from the NCI labs to the commercial sector. Stay tuned for upcoming news about this partnership’s plans to launch a new and exciting commercialization event.

About The Center for Advancing Innovation (CAI)

The Center for Advancing Innovation is global innovation intermediary focused on commercializing market viable innovations, increasing the success of startups and entrepreneurship and making an economic impact with these efforts. CAI focuses on all industries; at present, the focus is biotechnology, biopharma, medical devices, healthcare services, Health IT, e-health, mobile health, electronic medical records, health informatics, biohealth cyber security, high tech as well as internet/social media type inventions. For more information, please visit http://www.thecenterforadvancinginnovation.org.

About the NIH Office of Technology Transfer (NIH OTT)

OTT manages the patenting and licensing of a wide range of inventions made by scientists working for the NIH and FDA intramural research programs as mandated by the Federal Technology Transfer Act and related legislation. OTT also facilitates access to NIH and FDA inventions by developing research relationships between NIH and FDA intramural scientists with researchers in businesses and higher educational institutions. More information can be found at http://www.ott.nih.gov.

About the NCI Technology Transfer Center (NCI TTC)

NCI TTC serves as the Institute’s focal point for implementation of the Federal Technology Transfer Act by working closely with NCI investigators and outside parties to facilitate commercialization efforts to benefit public health. In this role it manages the NCI patent portfolio and utilizes these patents as incentive for commercial development of technologies, and establishes formal collaborative R&D partnerships among academia, federal laboratories, and industry.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10981539.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Block O'Toole & Murphy, LLP Personal Injury Trial Lawyers Take $2,270,000 Verdict In Brooklyn Motor Vehicle Accident Case
2. H&HN Takes Home Another ‘Magazine of the Year’ Award
3. Diet Doc Weight Loss Diets & Weight Loss Plans Announces Refurbished Medical Diet Plans Designed to Melt Pounds and Inches Without Strenuous Exercise Regimens
4. Gloria Rand - SEO Copywriter Joins Team in Training in Orlando, FL to Raise Money for Fight against Leukemia & Lymphoma
5. Specialty Drug Delivery Firm Integral BioSystems LLC to Participate in Contract Pharma Magazine’s 12th Annual Contracting & Outsourcing Conference & Tabletop Exhibition
6. Scott Sheldon – Specialist in Healthcare and Life Sciences Supply Chain & Official Sponsor of LogiPharma 2013
7. Augmented Reality & Virtual Reality Market is Growing at a CAGR of 15.18% & will Reach 1.06 Billion by 2018 - New Report by MarketsandMarkets
8. Spectrum Surgical Offers Veterinary Gold-Handled Needle Holder Repair & Refurbishing Services
9. International Fitness Celebrity Jennifer Nicole Lee Will Be Featured as a Top Presenter & Group Instructor at the World Famous Fitness Celebrity Festival Sweat Miami
10. Diet Doc Weight Loss Diets & Diet Plans Announces New, Satisfying Healthy Food Recipes and Clean Eating Diets that Reduce Body Fat without Uncontrollable Hunger
11. Embedded IC & Die Technologies Patent Market Analysis & Survey Report Now Available at ReportsnReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: